Review

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019
1235 1438

Neurotransmitters and hair loss

Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.020
1589 9443

RIPK1 and obesity-induced inflammation

Aslı Melike Ekmekçi, Fehmi Balandi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.021
1349 1255

Terazosin and neuroprotection

Ayşe Yürekli, Atakan Ölçenoğlu, Manolya Yıldız, Begüm Arda, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.022
1953 1650

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023
2249 3646

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024
1679 1731

Subgenual anterior cingulate cortex and psychiatric disorders

Berfin Sıla Akdoğdu, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.025
1455 1220

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026
1255 1468

Superparamagnetic iron oxide nanoparticles use in the temporal lobe epilepsy model

Özge Çağlar, Elif Özyılmaz, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.027
1218 1295

Effect of mitochondrial dysfunction and oxidative stress on the pathogenesis of autism spectrum disorders

Umut Yücel, İrem Kahramanoğlu, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.028
2378 1530

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029
1569 2166